Michael H. Silber

Michael H. Silber

Auto-generated profile, based on publicly available information

Michael H. Silber

Center for Sleep Medicine and Department of Neurology, Mayo Clinic College of Medicine and Science, Rochester, MN

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Mayo Clinic Proceedings
Verified
Journal Article
Open access
MSMichael H. Silber
Michael H. Silber
MBMark J. Buchfuhrer
Mark J. Buchfuhrer
CEChristopher J. Earley
Christopher J. Earley
BKBrian B. Koo
Brian B. Koo
MMMauro Manconi
Mauro Manconi
JWJohn W. Winkelman
John W. Winkelman
Restless legs syndrome (RLS) is a common disorder. The population prevalence is 1.5% to 2.7% in a subgroup of patients having more severe RLS with symptoms occurring 2 or more times a week and causing at least moderate distress. It is important for primary care physicians to be familiar with the disorder and its management. Much has changed in the management of RLS since our previous revised algorithm was published in 2013. This updated algorithm was written by members of the Scientific and Medical Advisory Board of the RLS Foundation based on scientific evidence and expert opinion. A literature search was performed using PubMed identifying all articles on RLS from 2012 to 2020. The management of RLS is considered under the following headings: General Considerations; Intermittent RLS; Chronic Persistent RLS; Refractory RLS; Special Circumstances; and Alternative, Investigative, and Potential Future Therapies. Nonpharmacologic approaches, including mental alerting activities, avoidance of substances or medications that may exacerbate RLS, and oral and intravenous iron supplementation, are outlined. The choice of an alpha2-delta ligand as first-line therapy for chronic persistent RLS with dopamine agonists as a second-line option is explained. We discuss the available drugs, the factors determining which to use, and their adverse effects. We define refractory RLS and describe management approaches, including combination therapy and the use of high-potency opioids. Treatment of RLS in pregnancy and childhood is discussed.

1 May 2021 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
KGKriti D. Gandhi
Kriti D. Gandhi
MMMeghna Mansukhani
Meghna Mansukhani
MSMichael H. Silber
Michael H. Silber
BKBhanu Prakash Kolla
Bhanu Prakash Kolla

1 March 2021 in Sleep Medicine
Verified
Journal Article
Open access
LTLuke N. Teigen
Luke N. Teigen
Richard SharpRichard Sharp
Richard Sharp
JHJessica R. Hirsch
Jessica R. Hirsch
ECEmmaling Campbell
Emmaling Campbell
PTPaul C. Timm
Paul C. Timm
ELErik K. St Louis
Erik K. St Louis
Most middle-aged and older adult patients with isolated (idiopathic) REM sleep behavior disorder (RBD) eventually develop parkinsonism, dementia with Lewy bodies, or multiple system atrophy. We aimed to describe the current sleep medicine specialist approach toward RBD prognostic counseling, and to determine physician beliefs and characteristics that impact provision of counseling. We surveyed 70 sleep medicine physicians with RBD expertise for demographic information, counseling practices, and their beliefs and understandings concerning the association between RBD and synucleinopathies, among other questions. Responses were summarized by descriptive statistics. Among the 44 respondents (63% response rate), 41 (93.2%) regularly provided prognostic counseling for most RBD patients, but only 31.8% routinely asked about patient preferences on receiving counseling. 41.8% believed that the risk for developing overt synucleinopathy following RBD diagnosis was >80%, but only 15.9% routinely provided this detailed phenoconversion risk estimate to their patients. Most respondents were concerned that RBD prognostic counseling could adversely impact on the patient's and family's mental health. Most expert RBD sleep clinicians routinely counsel their patients regarding the high risk for phenoconversion to parkinsonism or dementia, yet relatively few routinely ask patients about their preferences for receiving this information, and fewer provide details concerning the known high risk estimates for developing a synucleinopathy. Future research should analyze patients' values and preferences in RBD populations to inform approaches toward shared decision making for RBD prognostic counseling.

1 January 2013 in Neurology
Verified
Journal Article
Closed access
PDF file
EFEoin P. Flanagan
Eoin P. Flanagan
RGRalitza H. Gavrilova
Ralitza H. Gavrilova
BBBradley F. Boeve
Bradley F. Boeve
NKNeeraj Kumar
Neeraj Kumar
EJElena J. Jelsing
Elena J. Jelsing
MSMichael H. Silber
Michael H. Silber

1 September 2006 in Chest
Verified
Journal Article
Closed access
PDF file
TYTimothy J. Young
Timothy J. Young
MSMichael H. Silber
Michael H. Silber

1 January 2001
Verified
Book
Closed access
MTMichael J. Thorpy
Michael J. Thorpy
Giuseppe PlazziGiuseppe Plazzi
Giuseppe Plazzi
IAImran M. Ahmed
Imran M. Ahmed
RARichard P. Allen
Richard P. Allen
CBCarl W. Bazil
Carl W. Bazil
ELElio Lugaresi
Elio Lugaresi
The first authoritative review on the parasomnias - disorders that cause abnormal behavior during sleep - this book contains many topics never before covered in detail. The behaviors associated with parasomnias may lead to injury of the patient or bed-partner, and may have forensic implications. These phenomena are common but often unrecognized, misdiagnosed, or ignored in clinical practice. With increasing awareness of abnormal behaviors in sleep, the book fulfils the need for in-depth descriptions of clinical and research aspects of these disorders, including differential diagnosis, pathophysiology, morbidity, and functional consequences of each condition, where known. Appropriate behavioral and pharmacological treatments are addressed in detail. There are authoritative sections on disorders of arousal, parasomnias usually associated with REM sleep, sleep-related movement disorders and other variants, and therapy of parasomnias. Sleep specialists, neurologists, psychiatrists, psychologists and other healthcare professionals with an interest in sleep disorders will find this book essential reading.